Allergan Stock Price (NYSE:AGN)

Add to My Stocks
$190.75 $5.15 (2.77%) AGN stock closing price Aug 20, 2018 (Closing)
Prev Close* : $185.6
Market Cap:
$63B
Day Low: $186.1
52 Week Low: $142.81
Open: $186.13
Volume: -
Day High: $191.8
52 Week High: $237.41
Dividend:
2.88

Allergan Stock Articles & Video

more news on AGN stock

Allergan News - From Partners

AGN Stockcharts

View AGN PE ratio, PS ratio stocks charts and compare with peers.
AGN Chart
Note: Compare Allergan stock price history with the index and industry peers.

Allergan Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
3.9
PB ratio (
price to book ratio
)
0.87

Allergan Returns

ROE
(return on equity)
-2%

Allergan Financial Ratios

Asset Turnover
0.15
Receivables Turnover
5.81
Debt to Equity
0.36
Dividend Yield
1.53%

AGN Industry Peers

Company Price Change (%)
Teva Pharmaceutical (TEVA)25.651.43 (5.9%)
Mylan (MYL)38.410.26 (0.68%)
Merck (MRK)70.171.11 (1.61%)
Astrazeneca (AZN)38.850.73 (1.92%)
Glaxosmithkline (GSK)41.330.08 (0.19%)
Astrazeneca (AZN)38.850.73 (1.92%)
Glaxosmithkline (GSK)41.330.08 (0.19%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teva Pharmaceutical (TEVA)25.651.43 (5.9%)
Mallinckrodt (MNK)36.071.38 (3.98%)
Allergan (AGN)190.755.15 (2.77%)
Akorn (AKRX)19.480.49 (2.58%)
BAUSCH HEALTH (BHC)22.320.43 (1.96%)
Dr. Reddy's Laboratories (RDY)34.220.39 (1.15%)
Mylan (MYL)38.410.26 (0.68%)
Top gainers from Medical-Generic Drugs industry
* As of Aug 21, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)21.840.59 (2.63%)
Progenics Pharma (PGNX)7.670.14 (1.79%)
Supernus Pharma (SUPN)44.40.4 (0.89%)
Corium (CORI)8.890.04 (0.45%)
Top losers from Medical-Generic Drugs industry
* As of Aug 21, 2018

Allergan plc Ordinary Shares Stock News - Partner Headlines

Allergan Financial Statements

income statement20172016201520142013
Net Sales or Revenues15.94B14.57B15.07B13.06B8.68B
Net Income-4.13B14.97B3.92B-1.63B-750.4M
Total Operating Expense19.69B14.54B13.28B8.03B4.41B
View Allergan income statement
balance sheet20172016201520142013
Total Assets118.34B128.99B135.84B52.53B22.73B
Total Liabilities44.5B52.79B59.25B24.19B13.19B
Shareholders Equity73.84B76.2B76.59B28.34B9.54B
View Allergan balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities933.9M-726.5M-1.27B-431.9M-163.6M
Net Cash from (used by) Operating Activities5.87B1.43B4.53B2.24B1.21B
Increase (Decrease) in Prop Plant And Equipment-342.8M-298.1M-314.8M-224.9M-170.8M
View Allergan cash flow statement

Allergan Stock Message Board

Allergan stock gained 2.77%, and the last close price as of Aug 20, 2018 is $190.75 for AGN stock. Allergan market capitalization is $63B and it represents the total market value of AGN stock. Allergan valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Allergan stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Allergan stock quote data shows the number of shares traded. For Ex: 2,112,374 Allergan shares were traded as of last trading day, as seen from Allergan stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Allergan dividend per share was 2.88 during the last quarter. One can observe stock price trends and check for volatility by checking Allergan stock price history.